山东朗诺制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
13
NMPA:13
Drug Approvals
Paracetamol and Ibuprofen Tablets
- Product Name
- 对乙酰氨基酚布洛芬片
- Approval Number
- 国药准字H20254285
- Approval Date
- May 27, 2025
NMPA
Potassium Chloride Oral Solution
- Product Name
- 氯化钾口服溶液
- Approval Number
- 国药准字H20254245
- Approval Date
- May 27, 2025
NMPA
Metformin Hydrochloride and Empagliflozin Tablets（Ⅵ）
- Product Name
- 二甲双胍恩格列净片(Ⅵ)
- Approval Number
- 国药准字H20253796
- Approval Date
- Apr 1, 2025
NMPA
Metformin Hydrochloride and Empagliflozin Tablets（I）
- Product Name
- 二甲双胍恩格列净片(Ⅰ)
- Approval Number
- 国药准字H20253795
- Approval Date
- Apr 1, 2025
NMPA
Vonoprazan Fumarate Tablets
- Product Name
- 富马酸伏诺拉生片
- Approval Number
- 国药准字H20253458
- Approval Date
- Feb 25, 2025
NMPA
Vonoprazan Fumarate Tablets
- Product Name
- 富马酸伏诺拉生片
- Approval Number
- 国药准字H20253457
- Approval Date
- Feb 25, 2025
NMPA
Raltitrexed for Injection
- Product Name
- 注射用雷替曲塞
- Approval Number
- 国药准字H20244205
- Approval Date
- Jun 28, 2024
NMPA
Sunitinib Malate Capsules
- Product Name
- 苹果酸舒尼替尼胶囊
- Approval Number
- 国药准字H20234308
- Approval Date
- Oct 18, 2023
NMPA
Aripiprazole Oral Solution
- Product Name
- 阿立哌唑口服溶液
- Approval Number
- 国药准字H20234322
- Approval Date
- Oct 18, 2023
NMPA
Erlotinib Hydrochloride Tablets
- Product Name
- 盐酸厄洛替尼片
- Approval Number
- 国药准字H20233161
- Approval Date
- Feb 14, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found